Live Chat ×
Skip to main content

Living with AML - Emotional Impact

Description

In this webinar, Dr. Thomas LeBlanc from Duke University Hospital will discuss AML -  how the diagnosis and treatment decisions impact patients. He will also provide a basic overview of AML and current treatments. 

This webinar is brought to you by the generous support of Celgene and Jazz Pharmaceuticals. 

Contributors

  • Thomas LeBlanc, MD

    Dr. LeBlanc is a medical oncologist, palliative care physician, and patient experience researcher. His clinical practice focuses on the care of patients with hematologic malignancies, with a particular emphasis on myeloid conditions and acute leukemias including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs / MPDs, CML), as well as some lymphomas and multiple myeloma. Dr. LeBlanc is the recipient of a Junior Career Development Award grant from the National Palliative Care Research Center (NPCRC), a Sojourns Scholars Leadership Award from the Cambia Health Foundation, and a Mentored Research Scholar Grant from the American Cancer Society. He represents the Duke Cancer Institute, a National Comprehensive Cancer Network (NCCN) member, on the NCCN Panel for Acute Myeloid Leukemia. He completed residency training in Internal Medicine at Duke, as well as fellowships in Medical Oncology and Hospice and Palliative Medicine. He graduated from the Duke University School of Medicine, also earning a Master of Arts degree in Philosophy during that time, and served as Chief Medical Resident at the Durham VA Medical Center. He holds board certifications in Internal Medicine, Medical Oncology, and in Hospice and Palliative Medicine. He is actively involved with teaching of medical students and housestaff at Duke, particularly with regards to issues of patient-doctor communication, and is mentoring several Duke trainees on research projects.

March 28, 2019
Thu 4:00 PM EDT

Duration 1H 0M

Already Registered?